Invitrogen

ARHGAP25 Polyclonal Antibody

ARHGAP25 Antibody in Immunohistochemistry (Paraffin) (IHC (P))

图: 1 / 11

ARHGAP25 Antibody (PA5-57238) in IHC (P)

Immunohistochemical analysis of ARHGAP25 in human lymph node using ARHGAP25 Polyclonal Antibody (Product # PA5-57238) using Anti-ARHGAP25 antibody HPA035346.

ARHGAP25 Antibody in Immunohistochemistry (IHC)

Product Image Gallery

产品信息

PA5-57238

应用

建议稀释比

已发表文章

免疫印迹 (WB)

0.04-0.4 µg/mL

免疫组化 (IHC)

查看1篇已发表文章 1篇已发表文章

免疫组化（石蜡） (IHC (P))

1:200-1:500

产品规格

种属反应

Human

已发表种属

Human

宿主/亚型

Rabbit / IgG

分类

Polyclonal

类型

Antibody

抗原

Recombinant protein corresponding to Human ARHGAP25. Recombinant protein control fragment (Product #RP-95003).

查看免疫原

偶联物

Unconjugated Unconjugated Unconjugated

形式

Liquid

浓度

0.2 mg/mL

纯化类型

Antigen affinity chromatography

保存液

PBS, pH 7.2, with 40% glycerol

内含物

0.02% sodium azide

保存条件

Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.

运输条件

Wet ice

AB_2638145

产品详细信息

Immunogen sequence: IQRVMTMMIR DHEVLFPKSK DIPLSPPAQK NDPKKAPVAR SSVGWDATED LRISRTDSFS SMTSDSDTTS PTGQQPSDAF PEDSSKVPRE K

Highest antigen sequence identity to the following orthologs: Mouse - 77%, Rat - 76%.

靶标信息

ARHGAP25 encode negative regulators of Rho GTPases, which are implicated in actin remodeling, cell polarity, and cell migration.

仅用于科研。不用于诊断过程。未经明确授权不得转售。

Product References

ARHGAP25 Inhibits Pancreatic Adenocarcinoma Growth by Suppressing Glycolysis via AKT/mTOR Pathway.

International journal of biological sciences

Huang WK,Chen Y,Su H,Chen TY,Gao J,Liu Y,Yeh CN,Li S

PA5-57238 was used in Immunohistochemistry to conclude that ARHGAP25 acts as a tumor suppressor by inhibiting the AKT/mTOR signaling pathway, which might provide a therapeutic target for PAAD.

Wed Mar 30 00:00:00 UTC 2022

ARHGAP25 Inhibits Pancreatic Adenocarcinoma Growth by Suppressing Glycolysis via AKT/mTOR Pathway.

International journal of biological sciences

Huang WK,Chen Y,Su H,Chen TY,Gao J,Liu Y,Yeh CN,Li S

PA5-57238 was used in Immunohistochemistry to conclude that ARHGAP25 acts as a tumor suppressor by inhibiting the AKT/mTOR signaling pathway, which might provide a therapeutic target for PAAD.